-
Listing
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLes merWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Trading
Where European Government Bonds meet the futureFixed Income derivativesLes merTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLes merEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLes merEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Les merThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Regelverk
-
About Euronext
Euronext strategic planInnovate for Growth 2027Les merShaping capital markets for future generations
-
Listing
Strengthening Europe’s strategic autonomy through capital marketsCzechoslovak Group lists on EuronextLes merWorld’s largest defence IPO ever recorded.
Learn more about Euronext’s initiatives to enhance financing and visibility for European aerospace and defence companies -
Trading
Where European Government Bonds meet the futureFixed Income derivativesLes merTrade Mini Bond Futures on main European Government Bonds
-
Clearing
Step into Europe’s next phase of Repo ClearingRepo ClearingLes merEuronext is expanding its repo clearing services to boost market access, liquidity provision and collateral optimisation across Europe.
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLes merEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Les merThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperInvesting in the future of Europe with innovative indicesLes merThe first edition of the Euronext Index Outlook series with a particular focus on the European Strategic Autonomy Index.
- Regelverk
-
About Euronext
Euronext strategic planInnovate for Growth 2027Les merShaping capital markets for future generations
All Bell ceremonies
Page Filters
-
Electro Power Systems
| Paris
Electro Power Systems
EnterNext welcomes Electro Power Systems on Euronext in Paris
Carlalberto Guglielminotti, CEO of Electro Power Systems, rings the opening bell.
Electro Power Systems specializes in developing and manufacturing hydrogen-based systems for energy storage. The systems storage capacity (10 KWh up to 100 MWh) is an answer to the Energy Transition ranging from the auxiliary power supply (backup for telecom towers and data centers) to solutions for supporting the electricity grid for transmission and distribution (smart grids and renewables' integration) and finally to leverage a distrusted generation model with a full off-grid infrastructure.
81636b9331ed-e438-486c-a552-f9880360e9b6Electro Power Systems
EnterNext welcomes Electro Power Systems on Euronext in Paris
Carlalberto Guglielminotti, CEO of Electro Power Systems, rings the opening bell.
Electro Power Systems specializes in developing and manufacturing hydrogen-based systems for energy storage. The systems storage capacity (10 KWh up to 100 MWh) is an answer to the Energy Transition ranging from the auxiliary power supply (backup for telecom towers and data centers) to solutions for supporting the electricity grid for transmission and distribution (smart grids and renewables' integration) and finally to leverage a distrusted generation model with a full off-grid infrastructure.
Paris -
Electro Power Systems
| Paris
Electro Power Systems
EnterNext welcomes Electro Power Systems on Euronext in Paris
Carlalberto Guglielminotti, CEO of Electro Power Systems, rings the opening bell.
Electro Power Systems specializes in developing and manufacturing hydrogen-based systems for energy storage. The systems storage capacity (10 KWh up to 100 MWh) is an answer to the Energy Transition ranging from the auxiliary power supply (backup for telecom towers and data centers) to solutions for supporting the electricity grid for transmission and distribution (smart grids and renewables' integration) and finally to leverage a distrusted generation model with a full off-grid infrastructure.
81636b9331ed-e438-486c-a552-f9880360e9b6Electro Power Systems
EnterNext welcomes Electro Power Systems on Euronext in Paris
Carlalberto Guglielminotti, CEO of Electro Power Systems, rings the opening bell.
Electro Power Systems specializes in developing and manufacturing hydrogen-based systems for energy storage. The systems storage capacity (10 KWh up to 100 MWh) is an answer to the Energy Transition ranging from the auxiliary power supply (backup for telecom towers and data centers) to solutions for supporting the electricity grid for transmission and distribution (smart grids and renewables' integration) and finally to leverage a distrusted generation model with a full off-grid infrastructure.
Paris -
Sensorion
| Paris
Sensorion
EnterNext welcomes Sensorion on Alternext in Paris
Laurent Nguyen, CEO of Sensorion, rings the opening bell.
Sensorion specializes in the research and development of medicines for the treatment of inner ear disorders (dizziness or loss of balance, hearing problems, tinnitus, etc.).
The company has three products in its portfolio, all in the final phases of pre-clinical development.
816214e77663-6554-463b-8407-5754dcc6eb75Sensorion
EnterNext welcomes Sensorion on Alternext in Paris
Laurent Nguyen, CEO of Sensorion, rings the opening bell.
Sensorion specializes in the research and development of medicines for the treatment of inner ear disorders (dizziness or loss of balance, hearing problems, tinnitus, etc.).
The company has three products in its portfolio, all in the final phases of pre-clinical development.
Paris -
Sensorion
| Paris
Sensorion
EnterNext welcomes Sensorion on Alternext in Paris
Laurent Nguyen, CEO of Sensorion, rings the opening bell.
Sensorion specializes in the research and development of medicines for the treatment of inner ear disorders (dizziness or loss of balance, hearing problems, tinnitus, etc.).
The company has three products in its portfolio, all in the final phases of pre-clinical development.
816214e77663-6554-463b-8407-5754dcc6eb75Sensorion
EnterNext welcomes Sensorion on Alternext in Paris
Laurent Nguyen, CEO of Sensorion, rings the opening bell.
Sensorion specializes in the research and development of medicines for the treatment of inner ear disorders (dizziness or loss of balance, hearing problems, tinnitus, etc.).
The company has three products in its portfolio, all in the final phases of pre-clinical development.
Paris -
Plant Advanced Technologies
| Paris
Plant Advanced Technologies
EnterNext welcomes Plant Advanced Technologies on Alternext in Paris
Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.
Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.
81519cc485cf-53f4-4029-998c-356c8e9316fbPlant Advanced Technologies
EnterNext welcomes Plant Advanced Technologies on Alternext in Paris
Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.
Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.
Paris -
Plant Advanced Technologies
| Paris
Plant Advanced Technologies
EnterNext welcomes Plant Advanced Technologies on Alternext in Paris
Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.
Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.
81519cc485cf-53f4-4029-998c-356c8e9316fbPlant Advanced Technologies
EnterNext welcomes Plant Advanced Technologies on Alternext in Paris
Jean-Paul Fèvre, Founder and CEO of Plant Advanced Technologies (symbol: ALPAT), rings the opening bell.
Plant Advanced Technologies specializes in producing plant molecules and extracts for the pharmaceutical and cosmetic sectors. The company offers research contracts to industrial firms for updating technologies on new plants and supply contracts for molecules obtained from these plants.
Paris -
EnterNext welcomes OSE Pharma on Euronext in Paris
Dominique Costantini, co-founder et CEO of OSE Pharma, rings the closing bell.
OSE Pharma is a biotechnology group that specializes in the research and development of therapeutic products for the treatment of cancers and lung disease.
At the end of 2013, the group had a portfolio of 5 products in development phase, including 4 in phase II (colon, breast and ovarian cancer, and cystic fibrosis) and 1 in phase III (lung cancer).81455c94b09a-ab28-4cdf-b059-d13a7cc71681EnterNext welcomes OSE Pharma on Euronext in Paris
Dominique Costantini, co-founder et CEO of OSE Pharma, rings the closing bell.
OSE Pharma is a biotechnology group that specializes in the research and development of therapeutic products for the treatment of cancers and lung disease.
At the end of 2013, the group had a portfolio of 5 products in development phase, including 4 in phase II (colon, breast and ovarian cancer, and cystic fibrosis) and 1 in phase III (lung cancer).
Paris -
EnterNext welcomes OSE Pharma on Euronext in Paris
Dominique Costantini, co-founder et CEO of OSE Pharma, rings the closing bell.
OSE Pharma is a biotechnology group that specializes in the research and development of therapeutic products for the treatment of cancers and lung disease.
At the end of 2013, the group had a portfolio of 5 products in development phase, including 4 in phase II (colon, breast and ovarian cancer, and cystic fibrosis) and 1 in phase III (lung cancer).81455c94b09a-ab28-4cdf-b059-d13a7cc71681EnterNext welcomes OSE Pharma on Euronext in Paris
Dominique Costantini, co-founder et CEO of OSE Pharma, rings the closing bell.
OSE Pharma is a biotechnology group that specializes in the research and development of therapeutic products for the treatment of cancers and lung disease.
At the end of 2013, the group had a portfolio of 5 products in development phase, including 4 in phase II (colon, breast and ovarian cancer, and cystic fibrosis) and 1 in phase III (lung cancer).
Paris -
EnterNext welcomes Cerenis Therapeutics on Euronext in Paris
Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics, rings the opening bell.
Cerenis Therapeutics is specialized in research & development into HDL therapies (High Density lipoproteins) intended for the treatment of cardiovascular and metabolic disorders. HDLs, also known as good cholesterol, are fat and protein complexes that contribute to the transportation of cholesterol from the body's tissues to the liver and are linked to a decrease in the risk of atherosclerosis and coronary diseases.
At the end of 2014, the firm boasted a portfolio of 6 products, with 3 in pre-clinical development and 3 in phase I of clinical development.814406960ab3-2b68-435a-a498-085a3f581d96EnterNext welcomes Cerenis Therapeutics on Euronext in Paris
Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics, rings the opening bell.
Cerenis Therapeutics is specialized in research & development into HDL therapies (High Density lipoproteins) intended for the treatment of cardiovascular and metabolic disorders. HDLs, also known as good cholesterol, are fat and protein complexes that contribute to the transportation of cholesterol from the body's tissues to the liver and are linked to a decrease in the risk of atherosclerosis and coronary diseases.
At the end of 2014, the firm boasted a portfolio of 6 products, with 3 in pre-clinical development and 3 in phase I of clinical development.
Paris -
EnterNext welcomes Cerenis Therapeutics on Euronext in Paris
Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics, rings the opening bell.
Cerenis Therapeutics is specialized in research & development into HDL therapies (High Density lipoproteins) intended for the treatment of cardiovascular and metabolic disorders. HDLs, also known as good cholesterol, are fat and protein complexes that contribute to the transportation of cholesterol from the body's tissues to the liver and are linked to a decrease in the risk of atherosclerosis and coronary diseases.
At the end of 2014, the firm boasted a portfolio of 6 products, with 3 in pre-clinical development and 3 in phase I of clinical development.814406960ab3-2b68-435a-a498-085a3f581d96EnterNext welcomes Cerenis Therapeutics on Euronext in Paris
Jean-Louis Dasseux, President and CEO of Cerenis Therapeutics, rings the opening bell.
Cerenis Therapeutics is specialized in research & development into HDL therapies (High Density lipoproteins) intended for the treatment of cardiovascular and metabolic disorders. HDLs, also known as good cholesterol, are fat and protein complexes that contribute to the transportation of cholesterol from the body's tissues to the liver and are linked to a decrease in the risk of atherosclerosis and coronary diseases.
At the end of 2014, the firm boasted a portfolio of 6 products, with 3 in pre-clinical development and 3 in phase I of clinical development.
Paris -
PSA Peugeot Citroën celebrates return to CAC 40 at Paris opening bell
PSA Peugeot Citroën is back in the Index, driven by first results of its rebuilding plan "Back in the Race".
The very first year of its plan, PSA Peugeot Citroën achieved ahead on its target 2 main objectives out of 3, by generating €2.2 billion in operating Free Cash Flow and becoming net debt free at the en of 2014.
To celebrate this come back, Jean-Baptiste de Chatillon, CFO of PSA Peugeot Citroën rang the bell marking the opening of trading on markets in Paris.81366414e463-0bfb-49af-8dd9-47d66286907cPSA Peugeot Citroën celebrates return to CAC 40 at Paris opening bell
PSA Peugeot Citroën is back in the Index, driven by first results of its rebuilding plan "Back in the Race".
The very first year of its plan, PSA Peugeot Citroën achieved ahead on its target 2 main objectives out of 3, by generating €2.2 billion in operating Free Cash Flow and becoming net debt free at the en of 2014.
To celebrate this come back, Jean-Baptiste de Chatillon, CFO of PSA Peugeot Citroën rang the bell marking the opening of trading on markets in Paris.
Paris -
PSA Peugeot Citroën celebrates return to CAC 40 at Paris opening bell
PSA Peugeot Citroën is back in the Index, driven by first results of its rebuilding plan "Back in the Race".
The very first year of its plan, PSA Peugeot Citroën achieved ahead on its target 2 main objectives out of 3, by generating €2.2 billion in operating Free Cash Flow and becoming net debt free at the en of 2014.
To celebrate this come back, Jean-Baptiste de Chatillon, CFO of PSA Peugeot Citroën rang the bell marking the opening of trading on markets in Paris.81366414e463-0bfb-49af-8dd9-47d66286907cPSA Peugeot Citroën celebrates return to CAC 40 at Paris opening bell
PSA Peugeot Citroën is back in the Index, driven by first results of its rebuilding plan "Back in the Race".
The very first year of its plan, PSA Peugeot Citroën achieved ahead on its target 2 main objectives out of 3, by generating €2.2 billion in operating Free Cash Flow and becoming net debt free at the en of 2014.
To celebrate this come back, Jean-Baptiste de Chatillon, CFO of PSA Peugeot Citroën rang the bell marking the opening of trading on markets in Paris.
Paris -
CADES rings the bell to celebrate their bond issuance in RMB
Patrice Ract Madoux, Chairman of CADES, closes the trading day in Paris to celebrate the listing of their bond issuance in RMB
Created in 1996, CADES (Caisse d'Amortissement de la Dette Sociale) is an administrative public body owned and controlled by the French State. Its mission is to amortise the French social debt. To successfuly achieve its mission entrusted by French Parliament, CADES has the possibility to issue tradable debt securities. The outstanding success of this transaction underlines the confidence that international investors have in CADES, one of the first European issuer. They particularly appreciate the solidity of the French social debt amortization mechanism, as well as the quality of the resource that is collected among the population under the supervision of the French Parliament and the Constitutional Council. Since its establishment, CADES has amortised a total of €84.1 billion of French social debt on a total of €216.7 billion assumed since inception. This reduction in the French public debt is equivalent in amount to 4 percentage points of 2013 GDP. When the interest saving on the amortised debt is taken into account, the reduction equates to more than 5 per cent of GDP.
8130f5de9045-b875-4d80-a186-da85018c4d90CADES rings the bell to celebrate their bond issuance in RMB
Patrice Ract Madoux, Chairman of CADES, closes the trading day in Paris to celebrate the listing of their bond issuance in RMB
Created in 1996, CADES (Caisse d'Amortissement de la Dette Sociale) is an administrative public body owned and controlled by the French State. Its mission is to amortise the French social debt. To successfuly achieve its mission entrusted by French Parliament, CADES has the possibility to issue tradable debt securities. The outstanding success of this transaction underlines the confidence that international investors have in CADES, one of the first European issuer. They particularly appreciate the solidity of the French social debt amortization mechanism, as well as the quality of the resource that is collected among the population under the supervision of the French Parliament and the Constitutional Council. Since its establishment, CADES has amortised a total of €84.1 billion of French social debt on a total of €216.7 billion assumed since inception. This reduction in the French public debt is equivalent in amount to 4 percentage points of 2013 GDP. When the interest saving on the amortised debt is taken into account, the reduction equates to more than 5 per cent of GDP.
Paris -
CADES rings the bell to celebrate their bond issuance in RMB
Patrice Ract Madoux, Chairman of CADES, closes the trading day in Paris to celebrate the listing of their bond issuance in RMB
Created in 1996, CADES (Caisse d'Amortissement de la Dette Sociale) is an administrative public body owned and controlled by the French State. Its mission is to amortise the French social debt. To successfuly achieve its mission entrusted by French Parliament, CADES has the possibility to issue tradable debt securities. The outstanding success of this transaction underlines the confidence that international investors have in CADES, one of the first European issuer. They particularly appreciate the solidity of the French social debt amortization mechanism, as well as the quality of the resource that is collected among the population under the supervision of the French Parliament and the Constitutional Council. Since its establishment, CADES has amortised a total of €84.1 billion of French social debt on a total of €216.7 billion assumed since inception. This reduction in the French public debt is equivalent in amount to 4 percentage points of 2013 GDP. When the interest saving on the amortised debt is taken into account, the reduction equates to more than 5 per cent of GDP.
8130f5de9045-b875-4d80-a186-da85018c4d90CADES rings the bell to celebrate their bond issuance in RMB
Patrice Ract Madoux, Chairman of CADES, closes the trading day in Paris to celebrate the listing of their bond issuance in RMB
Created in 1996, CADES (Caisse d'Amortissement de la Dette Sociale) is an administrative public body owned and controlled by the French State. Its mission is to amortise the French social debt. To successfuly achieve its mission entrusted by French Parliament, CADES has the possibility to issue tradable debt securities. The outstanding success of this transaction underlines the confidence that international investors have in CADES, one of the first European issuer. They particularly appreciate the solidity of the French social debt amortization mechanism, as well as the quality of the resource that is collected among the population under the supervision of the French Parliament and the Constitutional Council. Since its establishment, CADES has amortised a total of €84.1 billion of French social debt on a total of €216.7 billion assumed since inception. This reduction in the French public debt is equivalent in amount to 4 percentage points of 2013 GDP. When the interest saving on the amortised debt is taken into account, the reduction equates to more than 5 per cent of GDP.
Paris -
Euronext celebrates International Women’s Day 2015 in Paris
Female personalities from BNP Paribas, Groupe BCPE, Ossiam, Korn Ferry ring the opening bell.
For the International Women's Day 2015, Dominique Aubernon, Director of BNP Paribas New Zealand LTD, Marguerite Bérard-Andrieu, Deputy Exceutive Director of Groupe BPCE, Isabelle Bourcier, Head of Business Development of Ossiam, Inès de Dinechin, Board Member of Euronext London Limited, and Victoria Lorenz, Senior Client Partner of Korn Ferry, wish to contribute to improve and accelerate women's access to higher level in organizational scale within societies.
The bell ceremony has been followed by a roundtable on the theme of "Make it happen : Women & Careers in Finance" with these female personalities.811579875823-4168-4ccc-b143-d3c89d17c68eEuronext celebrates International Women’s Day 2015 in Paris
Female personalities from BNP Paribas, Groupe BCPE, Ossiam, Korn Ferry ring the opening bell.
For the International Women's Day 2015, Dominique Aubernon, Director of BNP Paribas New Zealand LTD, Marguerite Bérard-Andrieu, Deputy Exceutive Director of Groupe BPCE, Isabelle Bourcier, Head of Business Development of Ossiam, Inès de Dinechin, Board Member of Euronext London Limited, and Victoria Lorenz, Senior Client Partner of Korn Ferry, wish to contribute to improve and accelerate women's access to higher level in organizational scale within societies.
The bell ceremony has been followed by a roundtable on the theme of "Make it happen : Women & Careers in Finance" with these female personalities.
Paris -
Euronext celebrates International Women’s Day 2015 in Paris
Female personalities from BNP Paribas, Groupe BCPE, Ossiam, Korn Ferry ring the opening bell.
For the International Women's Day 2015, Dominique Aubernon, Director of BNP Paribas New Zealand LTD, Marguerite Bérard-Andrieu, Deputy Exceutive Director of Groupe BPCE, Isabelle Bourcier, Head of Business Development of Ossiam, Inès de Dinechin, Board Member of Euronext London Limited, and Victoria Lorenz, Senior Client Partner of Korn Ferry, wish to contribute to improve and accelerate women's access to higher level in organizational scale within societies.
The bell ceremony has been followed by a roundtable on the theme of "Make it happen : Women & Careers in Finance" with these female personalities.811579875823-4168-4ccc-b143-d3c89d17c68eEuronext celebrates International Women’s Day 2015 in Paris
Female personalities from BNP Paribas, Groupe BCPE, Ossiam, Korn Ferry ring the opening bell.
For the International Women's Day 2015, Dominique Aubernon, Director of BNP Paribas New Zealand LTD, Marguerite Bérard-Andrieu, Deputy Exceutive Director of Groupe BPCE, Isabelle Bourcier, Head of Business Development of Ossiam, Inès de Dinechin, Board Member of Euronext London Limited, and Victoria Lorenz, Senior Client Partner of Korn Ferry, wish to contribute to improve and accelerate women's access to higher level in organizational scale within societies.
The bell ceremony has been followed by a roundtable on the theme of "Make it happen : Women & Careers in Finance" with these female personalities.
Paris -
EnterNext welcomes ECOSLOPS on Alternext in Paris
Michel Pingeot, CEO et co-founder of Ecoslops, rings the opening bell.
ECOSLOPS gives a second life to oil residues from shipping and produces recycled marine fuels. The company operates an innovating technology in the treatment of marine hydrocarbon waste. Based on a strong and growing demand, ECOSLOPS provides an economically sustainable and ecologically relevant solution to all players of the marine waste industry. Its first industrial unit has already been launched. The production is progressively ramping-up. This success enables the company to commit to signing three new projects by 2017. ECOSLOPS has all the necessary advantages to become a major player in the treatment of marine hydrocarbon waste.
810326abd6ba-b7c2-48f2-afbd-9ab65549b0b3EnterNext welcomes ECOSLOPS on Alternext in Paris
Michel Pingeot, CEO et co-founder of Ecoslops, rings the opening bell.
ECOSLOPS gives a second life to oil residues from shipping and produces recycled marine fuels. The company operates an innovating technology in the treatment of marine hydrocarbon waste. Based on a strong and growing demand, ECOSLOPS provides an economically sustainable and ecologically relevant solution to all players of the marine waste industry. Its first industrial unit has already been launched. The production is progressively ramping-up. This success enables the company to commit to signing three new projects by 2017. ECOSLOPS has all the necessary advantages to become a major player in the treatment of marine hydrocarbon waste.
Paris -
EnterNext welcomes ECOSLOPS on Alternext in Paris
Michel Pingeot, CEO et co-founder of Ecoslops, rings the opening bell.
ECOSLOPS gives a second life to oil residues from shipping and produces recycled marine fuels. The company operates an innovating technology in the treatment of marine hydrocarbon waste. Based on a strong and growing demand, ECOSLOPS provides an economically sustainable and ecologically relevant solution to all players of the marine waste industry. Its first industrial unit has already been launched. The production is progressively ramping-up. This success enables the company to commit to signing three new projects by 2017. ECOSLOPS has all the necessary advantages to become a major player in the treatment of marine hydrocarbon waste.
810326abd6ba-b7c2-48f2-afbd-9ab65549b0b3EnterNext welcomes ECOSLOPS on Alternext in Paris
Michel Pingeot, CEO et co-founder of Ecoslops, rings the opening bell.
ECOSLOPS gives a second life to oil residues from shipping and produces recycled marine fuels. The company operates an innovating technology in the treatment of marine hydrocarbon waste. Based on a strong and growing demand, ECOSLOPS provides an economically sustainable and ecologically relevant solution to all players of the marine waste industry. Its first industrial unit has already been launched. The production is progressively ramping-up. This success enables the company to commit to signing three new projects by 2017. ECOSLOPS has all the necessary advantages to become a major player in the treatment of marine hydrocarbon waste.
Paris